Growth • DaVita
DVA
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
2,4%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
2,2%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
2,9%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
15,3%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
13%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-0,5%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!